Department of Emergency Medicine, Dalhousie University, Halifax Infirmary, Halifax, NS, Canada.
Department of Emergency Medicine, Western University, London, ON, Canada.
CJEM. 2024 Nov;26(11):804-813. doi: 10.1007/s43678-024-00764-7. Epub 2024 Aug 27.
Patients requiring emergent endotracheal intubation are at higher risk of post-intubation hypotension due to altered physiology in critical illness. Post-intubation hypotension increases mortality and hospital length of stay, however, the impact of vasopressors on its incidence and outcomes is not known. This scoping review identified studies reporting hemodynamic data in patients undergoing emergent intubation to provide a literature overview on post-intubation hypotension in cohorts that did and did not receive vasopressors.
A systematic search of CINAHL, Cochrane, EMBASE and PubMed-Medline was performed from database inception until September 28, 2023. Two independent reviewers completed the title and abstract screen, full text review and data extraction per PRISMA guidelines. Studies including patients < 18 years or intubations during cardiac arrest were excluded. Primary outcome was the presence of hypotension within 30 min of emergent intubation. Secondary outcomes included mortality at 1 h and in-hospital.
The systematic search yielded 13,126 articles, with 61 selected for final inclusion. There were 24,547 patients with a mean age of 57.2 years and a slight male predominance (63.8%). Respiratory failure was the most common intubation indication. Across 18 studies reporting on vasopressor use prior to intubation, 1171/7085 patients received vasopressors pre-intubation. Post-intubation hypotension occurred in 22.2% of patients across all studies, and in 34.3% of patients in studies where vasopressor administration pre-intubation was specifically reported. One-hour mortality of patients across all studies and within the vasopressor use studies was 1.2% and 1.6%, respectively. In-hospital mortality across studies was 21.5%, and 13.1% in studies which reported on vasopressor use pre-intubation.
Patients requiring emergent intubation have a high rate of post-intubation hypotension and in-hospital mortality. While there is an intuitive rationale for the use of vasopressors during emergent intubation, current evidence is limited to support a definitive change in clinical practice at this time.
由于危重病患者的生理状态发生改变,因此需要紧急进行气管插管的患者发生插管后低血压的风险更高。插管后低血压会增加死亡率和住院时间,但目前尚不清楚血管升压药对其发病率和结局的影响。本范围综述确定了报告接受紧急插管的患者血流动力学数据的研究,以提供关于接受和未接受血管升压药的患者队列中插管后低血压的文献综述。
从数据库创建开始到 2023 年 9 月 28 日,对 CINAHL、Cochrane、EMBASE 和 PubMed-Medline 进行了系统搜索。两名独立审查员按照 PRISMA 指南完成标题和摘要筛选、全文审查和数据提取。排除年龄<18 岁或心搏骤停期间插管的患者的研究。主要结局是在紧急插管后 30 分钟内出现低血压。次要结局包括 1 小时和住院时的死亡率。
系统搜索产生了 13,126 篇文章,最终有 61 篇文章入选。共有 24,547 名患者,平均年龄为 57.2 岁,男性略占优势(63.8%)。呼吸衰竭是最常见的插管指征。在 18 项报告插管前使用血管升压药的研究中,1171/7085 名患者在插管前接受了血管升压药。所有研究中,22.2%的患者发生插管后低血压,在专门报告插管前血管升压药给药的研究中,34.3%的患者发生插管后低血压。所有研究中患者的 1 小时死亡率为 1.2%,血管升压药使用研究中患者的 1 小时死亡率为 1.6%。研究中患者的住院死亡率为 21.5%,报告插管前使用血管升压药的研究中患者的住院死亡率为 13.1%。
需要紧急插管的患者发生插管后低血压和住院死亡率较高。虽然在紧急插管期间使用血管升压药有直观的合理性,但目前的证据还不足以支持此时对临床实践进行明确改变。